Share This! Tweet This! Recommend Us! Print Page

About Us

MIRI - Dr. Irwin with Patient 2015The National Cancer Institute’s (NCI) role is to eliminate suffering and death due to cancer. According to the NCI, approximately 85 percent of all cancer patients are treated in or near their communities, making cancer research programs in the community setting an opportunity to make significant contributions to clinical research and cancer care.

The NCI has worked to extend cancer research into the community since 1983. In 2014, the NW

NCORP received a $4.2 million, five-year, NCI-Sponsored grant to support more than 30 clinical oncology programs in offering cancer clinical trials and Cancer Care Delivery Research (CCDR) protocols in their communities.

The Northwest Community Oncology Research Program (NW NCORP)

The following organizations have partnered to form the Northwest Community Oncology Research Program (NW NCORP). The NW NCORP is a network of community hospitals, clinics, multidisciplinary providers, and researchers focused on providing consistent, efficient, quality care to the entire spectrum of cancer patients (pediatrics to aging adults). The partnership provides community-based settings to improve cancer patients’ access to new and emerging medical treatments and supportive care in four states: Washington, Utah, Alaska, and Idaho. Increasing access for minority and underrepresented populations is an additional focus of the network, which will engage in targeted outreach efforts to address cancer health disparities.

The NW NCORP’s partners have a common culture of patient-centered, high-value care and a shared commitment to federally sponsored community cancer research participation. They have embraced emerging technology-driven clinical care and communication tools to advance the community cancer research enterprise.

Cancer is the second leading cause of death in the United States and in 2016, an estimated 1.7 million new cases of cancer will be diagnosed in the country. The number of Americans currently living beyond a cancer diagnosis is nearly 14.5 million, and by 2024, the number of cancer survivors will grow significantly - up to almost 19 million.

The NW NCORP partnership is designed to address these growing statistics surrounding cancer by establishing and conducting community clinical trials for cancer screening, prevention, control, and post-treatment as well as Cancer Care Delivery Research (CCRD). CCDR examines how social factors, financing systems, organizational structures and processes, health technologies, and healthcare provider and individual behaviors affect patient outcomes, access to and quality of care, cancer care costs, and the health and well-being of cancer patients and survivors.